Rehabilitation after surgery for lumbar spinal stenosis Musculoskeletal Diseases
Conditions
Interventions
STRIDE is a physiotherapy-led, behaviour change programme that aims to provide wraparound (i.e. delivered before and after surgery) rehabilitation for people undergoing surgery for NC. It consists of
Sponsors
King's College Hospital NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. > = 50 years old 2. Symptoms of neurogenic claudication (defined as as pain/ aching/ heaviness/ weakness/ tingling/ numbness in one or both buttocks and/ or legs (with or without back pain), precipitated by walking/ prolonged standing and eased by sitting /bending forwards) 3. Radiographic evidence of degenerative lumbar spinal stenosis 4. On the waiting list for lumbar decompressive surgery (+/- fixation) to treat lumbar spinal stenosis 5. Conversational level English or willing to use an interpreter
Exclusion criteria
Exclusion criteria: 1. Lumbar spinal stenosis caused by tumour or fracture or significant deformity 2. Patients requiring urgent surgery (e.g. with cauda equina syndrome) 3. People who report other conditions as the primary reason that inhibits their walking 4. Unwilling to give informed consent 5. > 2 level instrumentation 6. < 10 weeks prior to surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acceptability measured using questionnaires based on the theoretical framework of acceptability after the pre-operative and post-operative phases of STRIDE. In addition, a focus group will be undertaken after the completion of the STRIDE programme. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Feasibility measures of recruitment, adherence and fidelity will be collected at the end of the intervention 2. Walking capacity will be measured with the six-minute walk test at baseline, 12 weeks and end of STRIDE intervention 3. Lower limb performance will be measured with timed 5-chair stands at baseline, 12 weeks and end of STRIDE intervention 4. Balance will be measured with the 4-pint balance test at baseline, 12 weeks and end of STRIDE intervention 5. Walking performance will be measured with the mean daily step count, collected over 7 days, using an accelerometer at baseline, 12 weeks and end of STRIDE intervention 6. Back-related disability will be measured with the Oswestry Disability Index at baseline, 12 weeks and end of STRIDE intervention 7. Fear of falling will be measured with the Short Falls Efficacy Scale International at baseline, 12 weeks and end of STRIDE intervention 8. Pain severity will be measured with the numerical rating scale at baseline, 12 weeks and end of STRIDE intervention 9. Illness perceptions will be measured with the Brief Illness Perceptions Questionnaire at baseline, 12 weeks and end of STRIDE intervention 10. Fear of movement will be measured with the Tampa Scale of Kinesiophobia at baseline, 12 weeks and end of STRIDE intervention 11. Satisfaction with the outcome of treatment will be measured with the Satisfaction scale from the valid Zurich Claudicant Scale at baseline, 12 weeks and end of STRIDE intervention 12. Impression of change will be measured with the Patient's Global Impression of change at baseline, 12 weeks and end of STRIDE intervention | — |
Countries
England, United Kingdom
Contacts
Public ContactSuzanne McIlroy
Outcome results
None listed